Maravai Lifesciences Holdings MRVI
NASDAQ MRVI
$7.32 -0.05 (-0.68%)
At close: Sep 4, 2026 · 4:00 PM EDT

Maravai Lifesciences Holdings (MRVI) Payout Ratio (2020 - 2024)

Analysis

Maravai Lifesciences Holdings (MRVI) Payout Ratio (2020 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Maravai Lifesciences Holdings 1.09 Bn 1.02 Bn 20.65 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 0.00
Jun 30, 2024 -0.03
Jun 30, 2023 -0.11
Mar 31, 2023 -6.16
Dec 31, 2022 0.35
Sep 30, 2022 0.37
Jun 30, 2022 0.27
Mar 31, 2022 0.27
Dec 31, 2021 0.87
Sep 30, 2021 0.38
Jun 30, 2021 0.25
Mar 31, 2021 0.31
Dec 31, 2020 8.27
Sep 30, 2020 0.00
Jun 30, 2020 0.13